Finance

Lists
EMCURE:NSE
Emcure Pharmaceuticals Ltd
၂,၃၄၈.၉၀ ₹
-၀.၅၄%
(-၁၂.၈၀) 1D
နို ၁၆, GMT+၅:၃၀ ၁၅:၃၀:၀၀  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for EMCURE...
Open
၂,၃၅၀.၀၀ ₹
High
၂,၃၈၉.၈၀ ₹
Low
၂,၃၂၆.၆၀ ₹
Mkt. cap
ဋေ ၄.၄၅ သ
Avg. vol.
၂.၂၈ သိန်း
Volume
၁.၀၅ သိန်း
Dividend
၀.၁၅%
Quarterly dividend
၀.၉၀ ₹
Ex-dividend date
၂၀၂၆ စက် ၄
P/E ratio
၄၉.၃၁
52-wk high
၂,၄၂၉.၉၀ ₹
52-wk low
၁,၃၁၂.၃၀ ₹
EPS
၄၇.၆၄ ₹
No. of employees
၇ ထောင်
Open
၂,၃၅၀.၀၀ ₹
High
၂,၃၈၉.၈၀ ₹
Low
၂,၃၂၆.၆၀ ₹
Mkt. cap
ဋေ ၄.၄၅ သ
Avg. vol.
၂.၂၈ သိန်း
Volume
၁.၀၅ သိန်း
Dividend
၀.၁၅%
Quarterly dividend
၀.၉၀ ₹
Ex-dividend date
၂၀၂၆ စက် ၄
P/E ratio
၄၉.၃၁
52-wk high
၂,၄၂၉.၉၀ ₹
52-wk low
၁,၃၁၂.၃၀ ₹
EPS
၄၇.၆၄ ₹
No. of employees
၇ ထောင်
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၃၆ မိနစ်
Nearly a fifth of the S&P 500 is tied to three men with no clear successors
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၄၂ မိနစ်
Dow Jones, Nasdaq, S&P 500 weekly preview: Nvidia earnings, Anthropic IPO on deck
Business Insider
Business Insider
·
ပြီးခဲ့သည့် ၃ နာရီ
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
FXEmpire
FXEmpire
·
ပြီးခဲ့သည့် ၂၃ မိနစ်
Why The S&P 500 Could Fall 63% – And Still Only Be Fairly Valued
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees၆.၉၁ ထောင်
Founded၁၉၈၁ ဧ ၁၆
Headquarters-
SectorHealth Care
Industry-
Websiteemcure.com
Last report
၂၀၂၆ နို ၃
Fiscal period
Q2 2027
၁၇.၁၄ ₹ / ၁၄.၉၀ ₹
+၁၅.၀၃%beat
Revenue / Est. (INR)
ဋေ ၂.၈၂ ထ / ဋေ ၂.၆၅ ထ
+၆.၃၅%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
ဋေ ၂.၃၆ ထ
ဋေ ၂.၄၇ ထ
ဋေ ၂.၅၈ ထ
ဋေ ၂.၈၂ ထ
Cost of goods sold
၉၆၂.၄၃ ဋေ
ဋေ ၁.၀၉ ထ
ဋေ ၁.၀၇ ထ
ဋေ ၁.၁၄ ထ
Cost of revenue
၉၆၂.၄၃ ဋေ
ဋေ ၁.၀၉ ထ
ဋေ ၁.၀၇ ထ
ဋေ ၁.၁၄ ထ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃၈၇.၃၃ ဋေ
၇၂၀.၇၂ ဋေ
၄၀၉.၅၀ ဋေ
၄၃၄.၇၁ ဋေ
Operating expense
ဋေ ၁.၀၅ ထ
၉၉၆.၉၄ ဋေ
ဋေ ၁.၁၁ ထ
ဋေ ၁.၂၁ ထ
Total operating expenses
ဋေ ၂.၀၁ ထ
ဋေ ၂.၀၉ ထ
ဋေ ၂.၁၈ ထ
ဋေ ၂.၃၆ ထ
Operating income
၃၅၅.၄၄ ဋေ
၃၇၉.၄၄ ဋေ
၃၉၈.၄၉ ဋေ
၄၆၅.၀၉ ဋေ
Other non operating income
၁.၈၅ ကုဋေ
-၃၆.၃၇ ကုဋေ
၂.၀၇ ကုဋေ
၃.၂၅ ကုဋေ
EBT including unusual items
၃၁၃.၇၉ ဋေ
၃၄၁.၁၈ ဋေ
၃၉၃.၅၃ ဋေ
၄၄၅.၈၅ ဋေ
EBT excluding unusual items
၃၅၁.၉၄ ဋေ
၃၇၂.၄၅ ဋေ
၃၉၁.၉၂ ဋေ
၄၄၅.၈၅ ဋေ
Income tax expense
၈၂.၄၂ ကုဋေ
၉၇.၄၄ ကုဋေ
၁၀၁.၀၃ ဋေ
၁၂၀.၇၈ ဋေ
Effective tax rate
၂၆.၂၇%
၂၈.၅၆%
၂၅.၆၇%
၂၇.၀၉%
Other operating expenses
၅၅၃.၆၀ ဋေ
၁၆၉.၉၄ ဋေ
၅၈၉.၈၀ ဋေ
၆၆၈.၆၃ ဋေ
Net income
၂၃၀.၅၄ ဋေ
၂၄၃.၄၀ ဋေ
၂၉၃.၉၈ ဋေ
၃၂၅.၅၆ ဋေ
Net profit margin
၉.၇၅%
၉.၈၆%
၁၁.၃၉%
၁၁.၅၄%
Earnings per share
၁၃.၆၇
၁၄.၇၀
၁၅.၃၄
၁၇.၁၄
Interest and investment income
-
၁.၆၈ ကုဋေ
-
-
Interest expense
-၃၇.၉၈ ကုဋေ
-၉.၂၅ ကုဋေ
-၃၁.၅၄ ကုဋေ
-၃၅.၅၈ ကုဋေ
Net interest expenses
-၃၇.၉၈ ကုဋေ
-၇.၅၇ ကုဋေ
-၃၁.၅၄ ကုဋေ
-၃၅.၅၈ ကုဋေ
Depreciation and amortization charges
၁၀၄.၆၈ ဋေ
၁၀၆.၂၇ ဋေ
၁၀၉.၅၀ ဋေ
၁၀၉.၆၆ ဋေ
EBITDA
၄၃၇.၂၉ ဋေ
၄၆၆.၇၁ ဋေ
၅၀၂.၂၅ ဋေ
၅၇၄.၆၈ ဋေ
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ